Up | AC
Home Page
Food and
Drug Administration
Blood Products Advisory Committee
December 14, 2006
BRIEFING INFORMATION (Un Redacted Version)
Reviews of analyses of pre-clinical studies and the clinical proposal for study of HBOC-201 in trauma subjects
Review 1: Albert F. Defelice, M.D., CDER, FDA (pdf)
Review 2: Thomas H. Hintze, Ph.D., New York Medical College, Valhalla, NY (pdf)
Review 3: John R. Hess, M.D., M.P.H., University of Maryland Medical School, Baltimore, MD (pdf)
Review 4: Carl J. Hauser, M.D., Beth Israel Deaconess Medical Center, Boston, MA (pdf)
Review 5: (Amendment) Albert F. Defelice, M.D., CDER, FDA (pdf)
Review 6: Donald D. Trunkey, M.D., Oregon Health & Science University, Portland, OR (pdf)
Review 7: Erik R. Swenson, M.D., VA Puget Sound Health Care System, Seattle, WA (pdf)
Review 8: Timothy G. Buchman, Ph.D., M.D., Washington University School of Medicine, St. Louis, MO (
pdf)